首页|孕妇抗核抗体谱与胎儿发育异常的关系

孕妇抗核抗体谱与胎儿发育异常的关系

扫码查看
目的:探讨孕妇抗核抗体谱与胎儿发育异常的关系.方法:选择2020 年1 月至2023 年 12 月在郑州大学第三附属医院行抗核抗体谱检测的孕妇2 490 例,通过胎儿四维彩超和超声心动图检测胎儿发育情况.使用免疫印迹法检测孕妇血清抗核抗体谱(抗双链DNA、核小体、组蛋白、核糖体蛋白P、SM、nRNP、SSA/Ro60、SSA/Ro52、SSB/La、着丝点、Scl-70 和Jo-1 抗体).比较胎儿发育正常和发育异常孕妇血清抗核抗体谱阳性检出情况,胎儿心脏发育正常和发育异常孕妇血清抗着丝点抗体、抗SSA/Ro52 抗体、抗着丝点或SSA/Ro52 抗体和抗SSA/Ro60+SSA/Ro52+SSB/La抗体阳性检出情况.分析抗核抗体谱在胎儿心脏异常中的诊断价值.结果:2 490 例孕妇抗核抗体谱阳性检出率为5.38%.胎儿发育异常孕妇抗核抗体谱阳性检出率为7.2%(37/514),高于胎儿发育正常孕妇的4.9%(97/1976)(P=0.040).胎儿发育正常和发育异常孕妇抗SSA/Ro60、SSA/Ro52、SSB/La和着丝点抗体阳性检出率比较,差异无统计学意义(P>0.05);78 例胎儿心脏异常,其中心血管畸形51 例、心律失常27 例.胎儿心脏发育正常和发育异常孕妇抗着丝点抗体、抗SSA/Ro52 抗体、抗着丝点或SSA/Ro52 抗体、抗SSA/Ro60+SSA/Ro52+SSB/La抗体阳性检出率比较,差异有统计学意义(P<0.05).孕妇抗着丝点或SSA/Ro52 抗体预测胎儿心脏发育异常的敏感度和阴性预测值分别为0.090 和0.971;抗着丝点抗体预测的特异度和阳性预测值分别为0.999和0.400.结论:孕妇血清抗着丝点抗体、抗SSA/Ro52 抗体以及抗SSA/Ro60+SSA/Ro52+SSB/La抗体阳性,可能提示胎儿心脏发育异常.
Relationship between anti-nuclear antibody spectrum in pregnant women and fetal developmental abnormalities
Aim:To explore the relationship between anti-nuclear antibody spectrum in pregnant women and fetal de-velopmental abnormalities.Methods:A total of 2 490 pregnant women who underwent anti-nuclear antibody spectrum exam-ination at the Third Affiliated Hospital of Zhengzhou University from January 2020 to December 2023 were selected,and fe-tal development was dectected through fetal four-dimensional ultrasound and fetal echocardiography.Immunoblotting method was used to detect the serum anti-nuclear antibody spectrum of pregnant women(anti-double stranded DNA antibody,anti-nucleosome antibody,anti-histone antibody,anti-ribosomal protein P antibody,anti-SM antibody,anti-nRNP antibody,anti-SSA/Ro60 antibody,anti-SSA/Ro52 antibody,anti-SSB/La antibody,anti-centromere antibody,anti-Scl-70 antibody,and anti-Jo-1 antibody).The positive detection rate of serum anti-nuclear antibody spectrum between pregnant women with ab-normal fetal development and those with normal fetal development was compared.The detection of serum anti-centromere an-tibody,anti-SSA/Ro52 antibody,anti-centromere or anti-SSA/Ro52 antibody,and anti-SSA/Ro60+SSA/Ro52+SSB/La antibodies in pregnant women with fetal cardiac abnormal and normal development was performed.The diagnostic value of anti-nuclear antibody spectrum in fetal cardiac abnormalities was analyzed.Results:The total positive detection rate of anti-nuclear antibody spectrum in 2 490 pregnant women was 5.38%.The positive rate of anti-nuclear antibody spectrum in pregnant women with abnormal fetal development was 7.2%(37/514),which was higher than that[4.9%(97/1 976)]in pregnant women with normal fetal development(P=0.040).There were no significant differences in the positive detection rate of anti-SSA/Ro60 antibody,anti-SSA/Ro52 antibody,anti-SSB/La antibody,or anti-centromere antibody between the abnormal fetal development group and the normal fetal development group(P>0.05),78 pregnant women had fetal cardiac development abnormalities,including 51 cases of cardiovascular malformations and 27 cases of arrhythmia.There were sig-nificant differences in the positive detection rate of anti-centromere antibody,anti-SSA/Ro52 antibody,anti-centromere or SSA/Ro52 antibodies,anti-SSA/Ro60+SSA/Ro52+SSB/La antibodies between pregnant women with fetal cardiac abnor-mal and normal development group(P<0.05).The sensitivity and negative predictive values of anti-centromere antibody or anti-SSA Ro52 antibody for predicting fetal cardiac abnormal development were the highest,with values of 0.090 and 0.971,respectively;the specificity and positive predictive values of anti-centromere antibody were 0.999 and 0.400,respec-tively.Conclusion:Pregnant women with positive anti-centromere antibody,anti-SSA/Ro52 antibodies,or anti-SSA/Ro60+SSA/Ro52+SSB/La antibodies by the anti-nuclear antibody spectrum might indicate abnormal fetal cardiac development.

anti-nuclear antibody spectrumanti-SSA antibodyanti-SSB antibodyfetal developmental abnormalityheart developmental abnormality

杜红梅、王全先、刘丽莎、马玲、牛超、袁恩武

展开 >

郑州大学第三附属医院检验医学科 郑州 450052

郑州市妊娠高血压疾病体外诊断重点实验室 郑州 450052

抗核抗体谱 抗SSA抗体 抗SSB抗体 胎儿发育异常 心脏发育异常

河南省医学科技攻关计划

SBGJ202302081

2024

郑州大学学报(医学版)
郑州大学

郑州大学学报(医学版)

CSTPCD北大核心
影响因子:1.246
ISSN:1671-6825
年,卷(期):2024.59(3)
  • 10